Daiwa dives in

How Daiwa plans to invest first biotech fund in Japan, Taiwan

The Daiwa Corporate Investment Co. Ltd. private equity arm of Daiwa Securities Group has for years made one-off investments in biotechs from its general funds. But the group decided a favorable investment climate for biotechs in Japan and Taiwan - including new government incentives for life science companies - marked an opportune time to raise its first biotech-specific fund.

Daiwa Taiwan-Japan Biotech Fund Investment L.P. closed with an initial ¥9.3 billion ($78.1 million) in January and will make its first investment this year.

Shuntaro Kodama,

Read the full 862 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE